You have not been diagnosed or treated
This is not a simple remote prescription request. The doctor may direct you to examination, urine testing, PSA assessment or urology.
Costa del Sol · Prescription medicine
Dutasterid på recepti Málaga
DutasteridAuthorised and off-label questionsThe clinical context must be clear
- Clarify why dutasteride is being requested
- Separate authorised use from hair-loss discussion
- English-speaking medical assessment
- Evidence-led repeat review when appropriate
Already on stable treatment? Use the repeat route only for an unchanged medicine and dose. If another provider started it, bring a named prescription, report or dispensing record. See the complete process →
In Spain, dutasteride is authorised for benign prostatic hyperplasia. Hair-loss use is not the authorised indication and is never an automatic online pathway.EngelsktalandeRegistered doctor
Telefon eller videoPrivat konsultation
Recept via e-postNär det är lämpligt
Lokalt apotekStock checked separately
Medicinskt ansvarig läkare
Dr Ben Harry Clegg
Málaga registrering 292911940 · Nerja Medical Center NICA 55712
The indication changes the whole consultation.New prostate symptoms Hair-loss discussion Established repeat
Dutasteride for prostate symptoms and hair-loss questions are not the same route
The doctor needs to know why it was prescribed, who established treatment and what monitoring has taken place. Prostate symptoms may require examination, PSA interpretation or urology; a hair-loss request involves a separate benefit-risk discussion.
You are asking about an off-label use
The authorised Spanish indication is not hair loss. The clinician must explain alternatives and may decide not to prescribe.
A clinician already established treatment
Bring a prescription, report and relevant monitoring. A stable repeat may be considered only after safety and indication are confirmed.
Skillnaderna som spelar roll
Frågor värda att besvara innan behandlingen
Swipe to the right to read the full table →| Fråga | Nyckelpunkt |
|---|---|
| Vad är den godkända indikationen? | Treatment of moderate-to-severe symptoms of benign prostatic hyperplasia and reduction of related acute urinary retention or surgery risk. |
| Is it authorised for hair loss? | No. Hair-loss use is outside the authorised Spanish indication and requires explicit clinical judgement. |
| What monitoring may matter? | Prostate history, PSA interpretation, urinary symptoms, liver history and adverse effects may affect the plan. |
| Is it interchangeable with finasteride? | No. Do not switch, combine or change dose without a clinician reviewing the indication and risks. |
Two routes, clearly separatedRoute 1 Route 2
From your first question to safe ongoing care
Choose the route that matches your situation. New symptoms, a treatment change or a first request need a doctor consultation; a stable repeat needs an established record.
Starting treatment or something has changed
Book the doctor consultation
Choose a telephone or secure video appointment for a first assessment, new symptoms or treatment concerns.
Prata med doktorn
Discuss your history, current medicines, symptoms and whether Dutasteride fits the clinical picture.
Receive the prescription by email
Receive a REMP e-prescription by email when the doctor confirms that treatment is clinically appropriate.
Collect from a pharmacy
Present the REMP QR prescription at a participating pharmacy and check stock directly with the pharmacy.
Stable treatment and a repeat prescription
Book the repeat-prescription review
Use this route only when the medicine and dose are already established and nothing important has changed.
Send supporting documents
If another provider started treatment, send a named prescription, report or dispensing record. See the complete document process →
Receive the reviewed prescription
Receive the e-prescription when the supporting record is satisfactory and continuation remains clinically appropriate.
Collect from a pharmacy
Use the REMP QR prescription at a participating pharmacy; medicine availability and cost are controlled by the pharmacy.
Ha dessa uppgifter redo
- The original diagnosis and reason for treatment
- Prescription, report and current dose
- PSA or urology information where relevant
- Adverse effects, fertility concerns and all other medicines
Vet vad som händer härnäst
- Which indication and clinical route apply
- Whether remote review is sufficient
- Whether examination, tests or specialist care are needed
- Whether a repeat prescription is appropriate
Relevant lokal vägledning
Dutasteride care around Málaga
Patients staying in Málaga should bring the original box, ingredient name, dose and evidence of who prescribed dutasteride. A duty-pharmacy finder can help with opening hours, not stock. Urinary retention, fever, blood in urine or severe pain needs urgent local assessment.
Inför din bedömning
Frågor i Málaga
Can I request dutasteride for hair loss?
You may request a discussion, but hair loss is not the authorised Spanish indication and prescribing is not guaranteed.
Can I renew a prostate prescription online?
A review may be possible with clear records, but the doctor may require examination, PSA information or urology follow-up.
Is dutasteride stronger than finasteride?
They are different medicines with different authorised indications and risk-benefit considerations; “stronger” is not a safe basis for choosing.
Can I switch from finasteride myself?
No. Do not switch or combine them without medical review.
What if I cannot pass urine?
Seek urgent local medical care; do not wait for a routine teleconsultation.
Can women handle leaking capsules?
Women who are or may be pregnant should avoid contact with leaking capsules.
Hitta ett apotek i Málaga+
Use the official provincial duty-pharmacy finder. Select the correct municipality and date; it does not guarantee medicine stock.
Öppna den officiella Málaga-apotekssökaren ↗Nationell vägledning och närliggande orter+
Säkerheten först
Seek urgent care for inability to urinate, severe urinary pain, fever or blood in urine. Do not use a routine repeat route for new or worsening symptoms.
Officiella källor